News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
763,908 Results
Type
Article (65457)
Company Profile (428)
Press Release (698008)
Multimedia
Podcasts (216)
Webinars (31)
Section
Business (195552)
Career Advice (3446)
Deals (35450)
Drug Delivery (180)
Drug Development (85944)
Employer Resources (191)
FDA (17849)
Job Trends (15347)
News (345384)
Policy (36046)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3006)
Academic (1)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (207)
Alliances (50590)
ALS (241)
Alzheimer's disease (1980)
Antibody-drug conjugate (ADC) (576)
Approvals (18228)
Artificial intelligence (825)
ASCO (345)
Autoimmune disease (374)
Automation (68)
Bankruptcy (374)
Best Places to Work (11849)
BIO (76)
BIOSECURE Act (23)
Biosimilars (255)
Biotechnology (293)
Bladder cancer (215)
Brain cancer (85)
Breast cancer (846)
Cancer (6680)
Cardiovascular disease (561)
Career advice (2954)
Career pathing (52)
CAR-T (392)
CDC (77)
Celiac Disease (3)
Cell therapy (1088)
Cervical cancer (58)
Clinical research (74680)
Collaboration (2399)
Commercialization (1)
Company closure (8)
Compensation (1545)
Complete response letters (109)
COVID-19 (3017)
CRISPR (128)
C-suite (1307)
Cystic fibrosis (168)
Data (8876)
Decentralized trials (3)
Denatured (74)
Depression (198)
Dermatology (100)
Diabetes (712)
Diagnostics (7269)
Digital health (67)
Diversity (11)
Diversity, equity & inclusion (47)
Drug discovery (421)
Drug pricing (246)
Drug shortages (39)
Duchenne muscular dystrophy (330)
Earnings (80990)
Editorial (80)
Employer branding (22)
Employer resources (166)
Events (125981)
Executive appointments (1180)
FDA (22023)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1977)
Gene editing (277)
Generative AI (75)
Gene therapy (861)
GLP-1 (1280)
Government (5364)
Grass and pollen (8)
Guidances (420)
Healthcare (20208)
Hematology (197)
HIV (97)
Huntington's disease (69)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (116)
Immunology and inflammation (363)
Immuno-oncology (118)
Indications (225)
Infectious disease (3421)
Inflammatory bowel disease (245)
Inflation Reduction Act (16)
Influenza (153)
Intellectual property (329)
Interviews (671)
IPO (16795)
IRA (61)
Job creations (3824)
Job search strategy (2374)
JPM (72)
Kidney cancer (22)
Labor market (119)
Layoffs (677)
Leadership (53)
Legal (8589)
Liver cancer (111)
Longevity (36)
Lung cancer (883)
Lymphoma (487)
Machine learning (67)
Management (65)
Manufacturing (1247)
Marketing (4)
MASH (228)
Medical affairs (1)
Medical device (14446)
Medtech (14622)
Mergers & acquisitions (19998)
Metabolic disorders (1841)
mRNA (272)
Multiple sclerosis (208)
NASH (24)
Neurodegenerative disease (522)
Neuropsychiatric disorders (131)
Neuroscience (3769)
Neurotech (2)
NextGen: Class of 2026 (7064)
Non-profit (4894)
Now hiring (70)
Obesity (882)
Opinion (376)
Ovarian cancer (248)
Pain (287)
Pancreatic cancer (371)
Parkinson's disease (428)
Partnered (37)
Patents (670)
Patient recruitment (805)
Peanut (72)
People (60050)
Pharmaceutical (77)
Pharmacy benefit managers (38)
Phase 1 (23204)
Phase 2 (32709)
Phase 3 (24648)
Pipeline (10101)
Policy (402)
Postmarket research (2901)
Preclinical (10051)
Press Release (69)
Prostate cancer (352)
Psychedelics (73)
Radiopharmaceuticals (376)
Rare diseases (1315)
Real estate (6184)
Recruiting (77)
Regulatory (28370)
Reports (59)
Research institute (2728)
Resumes & cover letters (548)
Rett syndrome (47)
RNA editing (31)
RSV (99)
Schizophrenia (197)
Series A (339)
Series B (250)
Service/supplier (10)
Sickle cell disease (130)
Special edition (32)
Spinal muscular atrophy (184)
Sponsored (54)
Startups (3787)
State (2)
Stomach cancer (21)
Supply chain (148)
Tariffs (104)
The Weekly (140)
Vaccines (1315)
Venture capital (140)
Weight loss (598)
Women's health (140)
Worklife (25)
Date
Today (123)
Last 7 days (536)
Last 30 days (2568)
Last 365 days (32247)
2026 (17207)
2025 (32162)
2024 (36949)
2023 (41638)
2022 (52832)
2021 (57441)
2020 (55779)
2019 (48565)
2018 (36857)
2017 (34901)
2016 (34813)
2015 (39966)
2014 (33008)
2013 (27889)
2012 (29738)
2011 (29995)
2010 (28001)
Location
Africa (1045)
Alabama (99)
Alaska (7)
Arizona (361)
Arkansas (16)
Asia (45336)
Australia (7880)
California (14370)
Canada (3997)
China (1610)
Colorado (606)
Connecticut (641)
Delaware (441)
Europe (105372)
Florida (2171)
Georgia (459)
Hawaii (4)
Idaho (66)
Illinois (1220)
India (103)
Indiana (627)
Iowa (27)
Japan (613)
Kansas (138)
Kentucky (56)
Louisiana (62)
Maine (89)
Maryland (1734)
Massachusetts (10564)
Michigan (395)
Minnesota (786)
Mississippi (5)
Missouri (157)
Montana (34)
Nebraska (26)
Nevada (148)
New Hampshire (91)
New Jersey (3831)
New Mexico (35)
New York (3819)
North Carolina (1892)
North Dakota (11)
Northern California (7238)
Ohio (444)
Oklahoma (26)
Oregon (44)
Pennsylvania (2820)
Puerto Rico (32)
Rhode Island (51)
South America (1412)
South Carolina (87)
South Dakota (2)
Southern California (5676)
Tennessee (230)
Texas (2325)
United States (51250)
Utah (422)
Vermont (2)
Virginia (359)
Washington D.C. (86)
Washington State (1172)
West Virginia (4)
Wisconsin (155)
Wyoming (1)
763,908 Results for "the parkinson s institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
Biogen, Denali pull plug on Parkinson’s program after mid-stage flop
Biogen and Denali’s Parkinson’s disease drug failed to significantly slow disease progression in a Phase 2b study, missing both primary and secondary endpoints.
May 22, 2026
·
2 min read
·
Tristan Manalac
Parkinson’s disease
Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy
Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with Parkinson’s disease. Phase 1b/2a data showed that the asset can improve motor function and mobility in patients.
March 23, 2026
·
2 min read
·
Tristan Manalac
Parkinson’s disease
5 Investigational Therapies That Could Change the Parkinson’s Landscape
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC Immune, Gain Therapeutics and more could shape the future of Parkinson’s disease treatment.
January 26, 2026
·
9 min read
·
Tristan Manalac
Parkinson’s disease
FDA Warns of Seizure Risk With Some Parkinson’s Drugs
The FDA detected 14 cases of vitamin B6 deficiency–linked seizures and two deaths in patients with Parkinson’s disease taking carbidopa/levodopa drugs. Both AbbVie and Novartis market levodopa-based products.
March 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Parkinson’s Disease Programme
June 9, 2026
·
3 min read
Press Releases
Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease
June 30, 2026
·
8 min read
Press Releases
Merz Therapeutics Presents New Research at World Parkinson Congress 2026, Revealing the Hidden Burden of “OFF” Episodes in Parkinson’s Disease
May 28, 2026
·
4 min read
Press Releases
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
June 4, 2026
·
8 min read
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TMEM175 Agonists for Parkinson’s Disease
June 1, 2026
·
3 min read
1 of 76,391
Next
